U.S. patent application number 16/750224 was filed with the patent office on 2020-05-21 for systems and methods for treating a tissue site with reduced pressure involving a reduced-pressure interface having a cutting ele.
The applicant listed for this patent is KCI Licensing, Inc.. Invention is credited to Christopher Brian LOCKE, Timothy Mark ROBINSON, Aidan Marcus TOUT.
Application Number | 20200155736 16/750224 |
Document ID | / |
Family ID | 46584414 |
Filed Date | 2020-05-21 |
United States Patent
Application |
20200155736 |
Kind Code |
A1 |
LOCKE; Christopher Brian ;
et al. |
May 21, 2020 |
SYSTEMS AND METHODS FOR TREATING A TISSUE SITE WITH REDUCED
PRESSURE INVOLVING A REDUCED-PRESSURE INTERFACE HAVING A CUTTING
ELEMENT
Abstract
Systems and methods for a reduced-pressure interface for
providing reduced pressure through a sealing member to a
distribution manifold includes a housing having a flange portion
and a cavity wall portion such that the cavity wall portion forms a
cavity having a tissue-facing cavity opening. A conduit port is
coupled to the cavity wall and has a conduit aperture, such that
the conduit port is adapted to receive a reduced-pressure delivery
conduit. An attachment device is coupled to a tissue-facing side of
the flange portion of the housing such that the attachment device
couples the housing to the sealing member. Additionally, a cutting
element is at least temporarily coupled to the housing proximate to
the tissue-facing cavity opening such that the cutting element is
adapted to form an aperture in the sealing member when the cutting
element is driven into the sealing member with a driving force.
Inventors: |
LOCKE; Christopher Brian;
(Bournemouth, GB) ; ROBINSON; Timothy Mark;
(Shillingstone, GB) ; TOUT; Aidan Marcus;
(Alderbury, GB) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
KCI Licensing, Inc. |
San Antonio |
TX |
US |
|
|
Family ID: |
46584414 |
Appl. No.: |
16/750224 |
Filed: |
January 23, 2020 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
15842274 |
Dec 14, 2017 |
10576189 |
|
|
16750224 |
|
|
|
|
14276853 |
May 13, 2014 |
9878077 |
|
|
15842274 |
|
|
|
|
13554620 |
Jul 20, 2012 |
8758328 |
|
|
14276853 |
|
|
|
|
61511827 |
Jul 26, 2011 |
|
|
|
61511840 |
Jul 26, 2011 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61M 1/0088 20130101;
A61F 2013/00174 20130101; A61M 25/00 20130101; A61M 1/00 20130101;
A61F 2013/00536 20130101; A61M 2205/3344 20130101; A61F 2013/0054
20130101; A61M 1/0025 20140204; A61F 13/00068 20130101 |
International
Class: |
A61M 1/00 20060101
A61M001/00; A61M 25/00 20060101 A61M025/00; A61F 13/00 20060101
A61F013/00 |
Claims
1. An interface for treating a tissue site, the interface
comprising: a housing having a flange and a cavity wall, the cavity
wall comprising a bellows; a cutting element coupled to the
housing, the cutting element comprising: a conduit adapter
comprising a conduit aperture and a protrusion; an adapter flange
configured to be positioned on an exterior portion of the cavity
wall; a tube extension coupled to the adapter flange and configured
to mate with the conduit aperture; a base member coupled to the
tube extension; and a stylus member coupled to the base member; and
an attachment device coupled to a tissue-facing side of the flange
and configured to couple the flange to a sealing member; wherein
the bellows are configured to collapse and drive the cutting
element through the sealing member.
2. The interface of claim 1, further comprising a multi-lumen
conduit fluidly coupled to the conduit adapter.
3. The interface of claim 2, wherein the multi-lumen conduit
comprises a primary lumen and at least one sensing lumen.
4. The interface of claim 3, wherein the conduit aperture is
configured to receive the multi-lumen conduit and the protrusion is
configured to engage the primary lumen.
5. The interface of claim 4, wherein the protrusion is configured
to extend into the primary lumen and form an interference fit with
the primary lumen.
6. The interface of claim 4, wherein the protrusion is configured
to fluidly isolate the primary lumen from the at least one sensing
lumen.
7. The interface of claim 1, wherein the tube extension is
configured to extend through the conduit aperture.
8. The interface of claim 1, wherein the conduit adapter, the
adapter flange, and the tube extension are formed from at least one
of the following: plasticized polyvinyl chloride (PVC),
polyurethane, cyclic olefin copolymer elastomer, thermoplastic
elastomer, poly acrylic, silicone polymer, polyether block amide
copolymer.
9. The interface of claim 1, wherein the base member is temporarily
coupled to the tube extension.
10. The interface of claim 1, wherein the cutting element is formed
from a water soluble material.
11. The interface of claim 10, wherein the water soluble material
comprises at least one of the following: Polyvinyl alcohol (PVOH),
polyvinyl pyrrolidone, hydroxyl and carboxyl modified cellulose,
hydroxyl and carboxyl modified acrylics, starch, a sugar, a weak
acid, a salt, polyethylene oxide (PEO), polyethylene glycol
(PEG).
12. The interface of claim 1, wherein the base member is formed
from a water soluble material.
13. The interface of claim 12, wherein the water soluble material
comprises at least one of the following: Polyvinyl alcohol (PVOH),
polyvinyl pyrrolidone, hydroxyl and carboxyl modified cellulose,
hydroxyl and carboxyl modified acrylics, starch, a sugar, a weak
acid, a salt, polyethylene oxide (PEO), polyethylene glycol
(PEG).
14. The interface of claim 1, wherein the attachment device
comprises an adhesive.
15. The interface of claim 1, wherein the stylus comprises a first
blade and a second blade configured to make orthogonal cuts in the
sealing member.
16. The interface of claim 15, wherein the stylus is configured to
perforate the sealing member to form an access aperture in the
sealing member and to apply a tensile force on the access
aperture.
17. The interface of claim 1, wherein the bellows are configured to
collapse when a pressure inside the bellows is less than a
threshold pressure.
18. The interface of claim 1, wherein the bellows are configured to
collapse in response to a driving force applied to the bellows.
19. The interface of claim 18, wherein the driving force is
manually applied to the bellows.
20. The interface of claim 18, wherein the driving force comprises
reduced pressure applied to a cavity within the bellows.
21. An interface for treating a tissue site, the interface
comprising: a housing having a flange and a cavity wall, the cavity
wall comprising a bellows; a cutting element coupled to the
housing; and an attachment device coupled to a tissue-facing side
of the flange and configured to couple the flange to a sealing
member; wherein the bellows are configured to collapse and drive
the cutting element through the sealing member.
22. The interface of claim 20, wherein the cutting element further
comprises: a conduit adapter comprising a conduit aperture and a
protrusion; an adapter flange configured to be coupled to an
exterior portion of the cavity wall; a tube extension coupled to
the adapter flange; a base member coupled to the tube extension;
and a stylus member coupled to the base member and comprising a
first blade and a second blade.
23. The interface of claim 22, wherein the tube extension is
configured to mate with the conduit aperture.
24. The interface of claim 22, wherein the tube extension is
configured to extend through the conduit aperture.
25. The interface of claim 22, further comprising a multi-lumen
conduit fluidly coupled to the conduit adapter.
26. The interface of claim 25, wherein the multi-lumen conduit
comprises a primary lumen and at least one sensing lumen.
27. The interface of claim 26, wherein the conduit aperture is
configured to receive the multi-lumen conduit and the protrusion is
configured to engage the primary lumen.
28. The interface of claim 27, wherein the protrusion is configured
to extend into the primary lumen and form an interference fit with
the primary lumen.
29. The interface of claim 27, wherein the protrusion is configured
to fluidly isolate the primary lumen from the at least one sensing
lumen.
30. The interface of claim 22, wherein the base member is
temporarily coupled to the tube extension.
31. The interface of claim 22, wherein the conduit adapter, the
adapter flange, and the tube extension are formed from at least one
of the following: plasticized polyvinyl chloride (PVC),
polyurethane, cyclic olefin copolymer elastomer, thermoplastic
elastomer, poly acrylic, silicone polymer, polyether block amide
copolymer.
32. The interface of claim 22, wherein the stylus comprises a first
blade and a second blade configured to make orthogonal cuts in the
sealing member.
33. The interface of claim 32, wherein the stylus is configured to
perforate the sealing member to form an access aperture in the
sealing member and to apply a tensile force on the access
aperture.
34. The interface of claim 20, wherein the cutting element is
formed from a water soluble material.
35. The interface of claim 34, wherein the water soluble material
comprises at least one of the following: Polyvinyl alcohol (PVOH),
polyvinyl pyrrolidone, hydroxyl and carboxyl modified cellulose,
hydroxyl and carboxyl modified acrylics, starch, a sugar, a weak
acid, a salt, polyethylene oxide (PEO), polyethylene glycol
(PEG).
36. The interface of claim 20, wherein the attachment device
comprises an adhesive.
37. The interface of claim 20, wherein the bellows are configured
to collapse when a pressure inside the bellows is less than a
threshold pressure.
38. The interface of claim 20, wherein the bellows are configured
to collapse in response to a driving force applied to the
bellows.
39. The interface of claim 38, wherein the driving force is
manually applied to the bellows.
40. The interface of claim 38, wherein the driving force comprises
reduced pressure applied to a cavity within the bellows.
Description
RELATED APPLICATIONS
[0001] This application is a continuation of U.S. patent
application Ser. No. 15/842,274, filed Dec. 14, 2017, which is a
continuation of U.S. patent application Ser. No. 14/276,853, filed
May 13, 2014, now U.S. Pat. No. 9,878,077, which is a continuation
of U.S. patent application Ser. No. 13/554,620, filed Jul. 20,
2012, now U.S. Pat. No. 8,758,328, which claims the benefit, under
35 USC .sctn. 119(e), of the filing of U.S. Provisional Patent
Application Ser. No. 61/511,840, entitled "Systems and Methods for
Treating a Tissue Site with Reduced Pressure Involving a
Reduced-Pressure Interface having a Cutting Element," filed Jul.
26, 2011, and U.S. Provisional Patent Application Ser. No.
61/511,827, entitled "Systems and Methods for Treating a Tissue
Site with Reduced Pressure Involving a Reduced-Pressure Interface
having a Multi-Lumen Conduit for Contacting a Manifold," filed Jul.
26, 2011, which is incorporated herein by reference for all
purposes.
BACKGROUND
[0002] The present disclosure relates generally to medical
treatment systems and, more particularly, but not by way of
limitation, to systems, methods, and apparatuses for treating a
tissue site with reduced pressure involving a reduced-pressure
interface having a cutting element.
[0003] Clinical studies and practice have shown that providing a
reduced pressure in proximity to a tissue site augments and
accelerates the growth of new tissue at the tissue site. The
applications of this phenomenon are numerous, but application of
reduced pressure has been particularly successful in treating
wounds. This treatment (frequently referred to in the medical
community as "negative pressure wound therapy," "reduced pressure
therapy," or "vacuum therapy") provides a number of benefits, which
may include faster healing and increased formulation of granulation
tissue. Typically, reduced pressure is applied to tissue through a
manifold device. The porous pad contains cells or pores distributes
reduced pressure to the tissue and channel fluids that are drawn
from the tissue.
SUMMARY
[0004] According to an illustrative embodiment a reduced-pressure
interface for providing reduced pressure through a sealing member
to a distribution manifold includes a housing having a flange
portion and a cavity wall portion such that the cavity wall portion
forms a cavity having a tissue-facing cavity opening. A conduit
port is coupled to the cavity wall and has a conduit aperture, such
that the conduit port is adapted to receive a reduced-pressure
delivery conduit. An attachment device is coupled to a
tissue-facing side of the flange portion of the housing such that
the attachment device couples the housing to the sealing member.
Additionally, a cutting element is at least temporarily coupled to
the housing proximate to the tissue-facing cavity opening such that
the cutting element is adapted to form an aperture in the sealing
member when the cutting element is driven into the sealing member
with a driving force.
[0005] According to another illustrative embodiment a system for
treating a tissue site on a patient with reduced pressure includes
a distribution manifold for placing proximate to the tissue site, a
sealing member for covering the distribution manifold and a portion
of intact epidermis of the patient to form a sealed space, a
reduced-pressure interface for providing reduced pressure through
the sealing member to the distribution manifold, a reduced-pressure
source, and a reduced-pressure delivery conduit for fluidly
coupling the reduced-pressure source to the reduced-pressure
interface. The reduced-pressure interface includes a housing having
a flange portion and a cavity wall portion such that the cavity
wall portion forms a cavity having a tissue-facing cavity opening,
a conduit port coupled to the cavity wall and having a conduit
aperture such that the conduit port is adapted to receive the
reduced-pressure delivery conduit, an attachment device coupled to
a tissue-facing side of the flange portion of the housing such that
the attachment device couples the housing to the sealing member,
and a cutting element at least temporarily coupled to the housing
proximate to the tissue-facing cavity opening. The cutting element
is adapted to form an aperture in the sealing member when the
cutting element is driven into the sealing member with a driving
force.
[0006] According to another illustrative embodiment a method for
treating a tissue site on a patient with reduced pressure includes
disposing a distribution manifold proximate to the tissue site and
covering the distribution manifold and a portion of intact
epidermis of the patient with a sealing member to form a sealed
space in which the distribution manifold is disposed. The sealing
member has a first side and a second, tissue-facing side. The
method further includes providing a reduced-pressure source,
coupling a reduced-pressure interface proximate to the first side
of the sealing member, and fluidly coupling a reduced-pressure
delivery conduit between the reduced pressure source and the
reduced-pressure interface. The reduced-pressure interface includes
a housing having a wall portion such that the wall portion forms a
cavity having a tissue-facing cavity opening, a conduit port
coupled to the cavity wall for receiving the reduced-pressure
delivery conduit, an attachment device for coupling the
reduced-pressure interface to the sealing member, and a cutting
element at least temporarily coupled to the housing proximate to
the tissue-facing cavity opening such that the cutting element is
adapted to perforate the sealing member when the cutting element is
driven into the sealing member with a driving force. The method
also includes applying a driving force to the reduced-pressure
interface of sufficient strength to cause the cutting element to
perforate the sealing member.
[0007] According to yet another illustrative embodiment, an
interface for providing reduced pressure through a drape to a
manifold includes a housing having a flange portion and a cavity
wall portion. The cavity wall portion forms a cavity and a cavity
wall aperture is formed within the cavity wall portion for
receiving a tube. The interface further includes a coupler
positioned on a tissue-facing side of the flange portion of the
housing for attaching the housing to the drape and a protrusion
coupled to the housing proximate to the flange portion. The
protrusion extends beyond the tissue-facing side of the flange
portion of the housing and is configured to form an aperture in the
drape when the protrusion is driven into the drape with the reduced
pressure.
[0008] According to another illustrative embodiment, a system for
treating a wound with reduced pressure includes a manifold for
positioning adjacent the wound, a drape for covering the manifold
and a portion of intact epidermis of the patient to form a sealed
space, a reduced-pressure interface for providing reduced pressure
through the drape to the manifold, a reduced-pressure source, and a
conduit for fluidly coupling the reduced-pressure source to the
reduced-pressure interface. The reduced-pressure interface includes
a housing having a flange portion and a cavity wall portion. The
cavity wall portion forms a cavity and a cavity wall aperture is
formed within the cavity wall portion for receiving a tube. The
reduced-pressure interface further includes a coupler positioned on
a tissue-facing side of the flange portion of the housing for
attaching the housing to the drape and a protrusion coupled to the
housing proximate to the flange portion. The protrusion extends
beyond the tissue-facing side of the flange portion of the housing
and is configured to form an aperture in the drape when the
protrusion is driven into the drape with the reduced pressure.
[0009] In another illustrative embodiment, a method for treating a
wound on a patient with reduced pressure includes disposing a
manifold proximate to the wound, covering the manifold and a
portion of intact epidermis of the patient with a drape to form a
sealed space in which the manifold is disposed. The drape has a
first side and a second, tissue-facing side. The method further
includes providing a reduced-pressure source, coupling a
reduced-pressure interface proximate to the first side of the
drape, and fluidly coupling a tube between the reduced-pressure
source and the reduced-pressure interface. The reduced-pressure
interface includes a housing having a flange portion and a cavity
wall portion. The cavity wall portion forms a cavity and a cavity
wall aperture is formed within the cavity wall portion for
receiving a tube. The reduced-pressure interface further includes a
coupler positioned on a tissue-facing side of the flange portion of
the housing for attaching the housing to the drape and a protrusion
coupled to the housing proximate to the flange portion. The
protrusion extends beyond the tissue-facing side of the flange
portion of the housing and is configured to form an aperture in the
drape when the protrusion is driven into the drape with a driving
force. The method further includes applying the driving force to
the reduced-pressure interface of sufficient strength to cause the
protrusion to perforate the drape.
[0010] Other features and advantages of the illustrative
embodiments will become apparent with reference to the drawings and
detailed description that follow.
BRIEF DESCRIPTION OF THE DRAWINGS
[0011] FIG. 1 is a schematic perspective view of an illustrative
embodiment of a system for treating a tissue site with reduced
pressure;
[0012] FIG. 2 is a schematic, cross-sectional view of an
illustrative embodiment of a multi-lumen conduit of the system
shown in FIG. 1 taken along line 2-2;
[0013] FIG. 3 is a schematic, cross-sectional view of one
illustrative embodiment of a reduced-pressure interface having a
cutting element for use as part of a system for treating a tissue
site with reduced pressure;
[0014] FIG. 4 is a schematic, bottom view of the reduced-pressure
interface of FIG. 3;
[0015] FIG. 5A is a schematic, cross-sectional view of the
reduced-pressure interface of FIG. 3 under reduced pressure prior
to the cutting element perforating a sealing member;
[0016] FIG. 5B is another schematic, cross-sectional view of the
reduced-pressure interface of FIG. 3 under reduced pressure after
the cutting member has perforated the sealing member;
[0017] FIG. 5C is another schematic, cross-sectional view of the
reduced-pressure interface of FIG. 3 under reduced pressure after
the cutting member has perforated the sealing member and the
cutting element has been removed;
[0018] FIG. 6 is a schematic, top perspective view of another
illustrative embodiment of a reduced-pressure interface having a
cutting element for use as part of a system for treating a tissue
site with reduced pressure;
[0019] FIG. 7 is a schematic, cross-sectional view of the
reduced-pressure interface of FIG. 6;
[0020] FIG. 8 is a schematic, bottom perspective view of a portion
of the reduced-pressure interface of FIG. 6;
[0021] FIG. 9A is a schematic, cross-sectional view of the
reduced-pressure interface of FIGS. 6-8 being applied and prior to
reduced pressure being supplied;
[0022] FIG. 9B is a schematic, cross-sectional view of the
reduced-pressure interface of FIGS. 6-8 under reduced pressure
prior to the cutting element perforating a sealing member;
[0023] FIG. 9C is a schematic, cross-sectional view of the
reduced-pressure interface of FIGS. 6-8 under reduced pressure
after the cutting member has perforated the sealing member and the
cutting element has been removed; and
[0024] FIG. 10 is a schematic diagram of a representative pressure
set-up pattern.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
[0025] In the following detailed description of the illustrative
embodiments, reference is made to the accompanying drawings that
form a part hereof. These embodiments are described in sufficient
detail to enable those skilled in the art to practice the
invention, and it is understood that other embodiments may be
utilized and that logical structural, mechanical, electrical, and
chemical changes may be made without departing from the spirit or
scope of the invention. To avoid detail not necessary to enable
those skilled in the art to practice the embodiments described
herein, the description may omit certain information known to those
skilled in the art. The following detailed description is,
therefore, not to be taken in a limiting sense, and the scope of
the illustrative embodiments are defined only by the appended
claims. Unless otherwise indicated, as used herein, "or" does not
require mutual exclusivity.
[0026] The term "reduced pressure" as used herein generally refers
to a pressure less than the ambient pressure at a tissue site that
is being subjected to treatment. In most cases, this reduced
pressure will be less than the atmospheric pressure at which the
patient is located. Alternatively, the reduced pressure may be less
than a hydrostatic pressure associated with tissue at the tissue
site. Unless otherwise indicated, values of pressure stated herein
are gauge pressures. References to increases in reduced pressure
typically refer to a decrease in absolute pressure, and decreases
in reduced pressure typically refer to an increase in absolute
pressure.
[0027] Referring now to the drawings and initially to FIGS. 1-5C,
and specifically to FIGS. 1 and 3, a system 100 for treating a
tissue site 102 on a patient 104 with reduced pressure is
presented. The system 100 includes a reduced-pressure dressing 106
for disposing proximate the tissue site 102. The system 100 also
includes a reduced-pressure treatment unit 108 fluidly connected to
the reduced-pressure dressing 106 through a reduced-pressure
delivery conduit 110 for applying reduced pressure to the tissue
site 102. The reduced-pressure dressing 106 may further include a
distribution manifold 112, a sealing member 114, and a
reduced-pressure interface 116. The reduced-pressure interface 116
includes a cutting element 118 adapted to form an aperture 120 (see
FIG. 5B) in the sealing member 114. Including the cutting element
118 on the reduced-pressure interface 116 provides a number of
potential benefits. The benefits may include ease of application
and the reduction of error when forming the aperture 120. In a
non-limiting example, errors in (1) positioning the aperture 120 on
the dressing, (2) sizing of the aperture 120, and (3) the formation
of the aperture 120 may be reduced. Incorrectly forming the
aperture 120 may leave portions of the sealing member 114 in a
position that can block the aperture 120 when reduced pressure is
applied.
[0028] The system 100 may be used with various different types of
tissue sites 102. The tissue site 102 may be a wound 122 or wound
cavity. As shown in at least FIGS. 5A-5C, the tissue site 102 or
wound 122, may be through an epidermis 124 and into a subcutaneous
tissue 126 or any other tissue. The tissue site 102 may be the
bodily tissue of any human, animal, or other organism, including
bone tissue, adipose tissue, muscle tissue, dermal tissue, vascular
tissue, connective tissue, cartilage, tendons, ligaments, body
cavity or any other tissue. Treatment of the tissue site 102 may
include removal of fluids, e.g., exudate or ascites.
[0029] Referring still to FIGS. 1-5C, the distribution manifold 112
is proximate the tissue site 102 and has a first side 128 and a
second, tissue-facing side 130. The term "distribution manifold" as
used herein generally refers to a substance or structure that is
provided to assist in applying reduced pressure to, delivering
fluids to, or removing fluids from the tissue site 102. The
distribution manifold 112 typically includes a plurality of flow
channels or pathways that distribute fluids provided to and removed
from the tissue site 102 around the distribution manifold 112. In
one illustrative embodiment, the flow channels or pathways are
interconnected to improve distribution of fluids provided or
removed from the tissue site 102. The distribution manifold 112 may
be a biocompatible material that is capable of being placed in
contact with the tissue site 102 and distributing reduced pressure
to the tissue site 102. Examples of the distribution manifold 112
may include, without limitation, devices that have structural
elements arranged to form flow channels, such as, for example,
cellular foam, open-cell foam, porous tissue collections, liquids,
gels, and foams that include, or cure to include, flow channels.
The distribution manifold 112 may be porous and may be made from
foam, gauze, felted mat, or any other material suited to a
particular biological application. In one embodiment, the
distribution manifold 112 is a porous foam and includes a plurality
of interconnected cells or pores that act as flow channels. The
porous foam may be a polyurethane, open-cell, reticulated foam such
as GranuFoam.RTM. material manufactured by Kinetic Concepts,
Incorporated of San Antonio, Tex. In some situations, the
distribution manifold 112 may also be used to distribute fluids
such as medications, antibacterials, growth factors, and various
solutions to the tissue site 102. Other layers may be included in
or on the distribution manifold 112, such as absorptive materials,
wicking materials, hydrophobic materials, and hydrophilic
materials.
[0030] In one illustrative the distribution manifold 112 may be
constructed from bioresorbable materials that do not have to be
removed from a patient's body following use of the system 100.
Suitable bioresorbable materials may include, without limitation, a
polymeric blend of polylactic acid (PLA) and polyglycolic acid
(PGA). The polymeric blend may also include without limitation
polycarbonates, polyfumarates, and capralactones. The distribution
manifold 112 may further serve as a scaffold for new cell-growth,
or a scaffold material may be used in conjunction with the
distribution manifold 112 to promote cell-growth. A scaffold is a
substance or structure used to enhance or promote the growth of
cells or formation of tissue, such as a three-dimensional porous
structure that provides a template for cell growth. Illustrative
examples of scaffold materials include calcium phosphate, collagen,
PLA/PGA, coral hydroxy apatites, carbonates, or processed allograft
materials.
[0031] The distribution manifold 112 may be covered by the sealing
member 114, which may also be referred to as a drape. The sealing
member 114 forms a sealed space 132 over the tissue site 102. The
sealing member 114 has a first side 134, and a second,
tissue-facing side 136. The sealing member 114 may be any material
that provides a fluid seal. "Fluid seal," or "seal," means a seal
adequate to maintain reduced pressure at a desired site given the
particular reduced-pressure source or subsystem involved. The
sealing member 114 may, for example, be an impermeable or
semi-permeable, elastomeric material. "Elastomeric" means having
the properties of an elastomer. Elastomer generally refers to a
polymeric material that has rubber-like properties. More
specifically, most elastomers have ultimate elongations greater
than 100% and a significant amount of resilience. The resilience of
a material refers to the material's ability to recover from an
elastic deformation. Elastomers that are relatively less resilient
may also be used as these elastomers are more likely to tear when
faced with the cutting element 118. Examples of elastomers may
include, but are not limited to, natural rubbers, polyisoprene,
styrene butadiene rubber, chloroprene rubber, polybutadiene,
nitrile rubber, butyl rubber, ethylene propylene rubber, ethylene
propylene diene monomer, chlorosulfonated polyethylene, polysulfide
rubber, polyurethane (PU), EVA film, co-polyester, and silicones.
Additional, specific examples of dressing sealing member materials
include a silicone drape, 3M Tegaderm.RTM. drape, polyurethane (PU)
drape such as one available from Avery Dennison Corporation of
Pasadena, Calif. An additional, specific non-limiting example of a
dressing sealing member material includes a 30 .mu.m matt
polyurethane film such as the Inspire.TM. 2317 manufactured by
Exopack.TM. Advanced Coatings of Matthews, N.C.
[0032] An attachment device 134 may be used to hold the sealing
member 114 against a portion of the patient's intact epidermis 124
or another layer, such as a gasket or additional sealing member.
The attachment device 134 may take numerous forms. For example, the
attachment device 134 may be a medically acceptable adhesive, such
as a pressure-sensitive adhesive, that extends about a periphery or
all of the sealing member 114. The attachment device 134 may also
be a sealing ring or other device. The attachment device 134 is
disposed on the second, tissue-facing side of the sealing member
114. Before use, the attachment device 134 may be covered by a
release liner (not shown).
[0033] The reduced-pressure interface 116 may be positioned
adjacent to or coupled to the sealing member 114 to provide fluid
access to the distribution manifold 112. Another attachment device
138 similar to the attachment device 134 may be used to hold the
reduced-pressure interface 116 against the sealing member 114. The
reduced-pressure delivery conduit 110 fluidly couples the
reduced-pressure treatment unit 108 and the reduced-pressure
interface 116. The reduced-pressure interface 116 allows the
reduced pressure to be delivered to the tissue site 102. While the
amount and nature of reduced pressure applied to a tissue site will
typically vary according to the application, the reduced pressure
will typically be between -5 mm Hg (-667 Pa) and -500 mm Hg (-66.7
kPa) and more typically between -75 mm Hg (-9.9 kPa) and -300 mm Hg
(-39.9 kPa). For example, and not by way of limitation, the
pressure may be -12, -12.5, -13, -14, -14.5, -15, -15.5, -16,
-16.5, -17, -17.5, -18, -18.5, -19, -19.5, -20, -20.5, -21, -21.5,
-22, -22.5, -23, -23.5, -24, -24.5, -25, -25.5, -26, -26.5 kPa or
another pressure.
[0034] As shown, the reduced-pressure delivery conduit 110 is a
multi-lumen conduit. It should be understood, however, that the
reduced-pressure delivery conduit 110 may be in many forms and may
comprise a single lumen. The reduced-pressure delivery conduit 110
may include a primary lumen 142 and at least one sensing lumen 144.
In one illustrative embodiment the primary lumen 142 is a central
lumen 146 and the at least one sensing lumen 144 is one or more
peripheral lumens 148. The primary lumen 142 and the at least one
sensing lumen 144 are adapted to maintain fluid isolation between
the primary lumen 142 and the at least one sensing lumen 144 as the
reduced-pressure delivery conduit 110 transports fluids from the
reduced-pressure interface 116 to the reduced-pressure treatment
unit 108. Liquids or exudates communicated from the distribution
manifold 112 through the primary lumen 142 are removed from the
reduced-pressure delivery conduit 110 and retained within a
liquid-collection chamber (not explicitly shown) in fluid
communication with the reduced-pressure treatment unit 108. The at
least one sensing lumen 144 fluidly communicates reduced pressure
representative of the tissue site 102 to an instrumentation unit
150.
[0035] The reduced-pressure treatment unit 108 may include a
liquid-collection chamber, or a collection canister, and the
instrumentation unit 150 in fluid communication with a
reduced-pressure source 140. The instrumentation unit 150 may
include a microprocessor 154 adapted to process pressure signals
received by the reduced-pressure delivery conduit 110, monitor the
pressure signals, and issue alerts according to a pre-determined
pressure configuration. The pre-determined pressure configuration
may include a pressure set-up pattern of sustained decrease,
increase, and relative stability within an application time period
as will be described in more detail with respect to FIG. 10
below.
[0036] In an illustrative embodiment, the reduced-pressure source
140 is an electrically-driven vacuum pump. In another
implementation, the reduced-pressure source 140 may instead be a
manually-actuated or manually-charged pump that does not require
electrical power. The reduced-pressure source 140 instead may be
any other type of reduced pressure pump, or alternatively a wall
suction port such as those available in hospitals and other medical
facilities. The reduced-pressure source 140 may be housed within or
used in conjunction with the reduced-pressure treatment unit 108,
which may also include the instrumentation unit 150. The
instrumentation unit 150 may include sensors, processing units,
alarm indicators, memory, databases, software, display units, and
user interfaces that further facilitate the application of reduced
pressure treatment to the tissue site 102.
[0037] In one example, pressure-detection sensors (not shown)
located in the instrumentation unit 150 may be disposed at or near
the reduced-pressure source 140. The pressure-detection sensors may
receive pressure data, or a pressure signal, from the
reduced-pressure interface 116 via the at least one sensing lumen
144 that is dedicated to delivering reduced pressure data to the
pressure-detection sensors. The pressure signal or data may be
representative of a pressure at a distal end 186 of the at least
one sensing lumen 144. The pressure-detection sensors may
communicate with a processing unit that monitors and controls the
reduced pressure that is delivered by the reduced-pressure source
140. In one embodiment, the pressure-detection sensors communicate
with the processing unit to monitor whether the pressure signal
follows the pressure set-up pattern. In the event the pressure
signal does not follow the pressure set-up pattern within an
application time period that may be predetermined, the
instrumentation unit 150 provides an indication to a caregiver. The
indication may be in the form of a visual or audible alert or
alarm. Other indications may be used. In an alternative, but not
mutually exclusive, embodiment, the pressure-detection sensors may
communicate with the processing unit to monitor whether the
pressure signal does follow the pressure set-up pattern within an
application time period. In the event the pressure signal does
follow the pressure set-up pattern, the instrumentation unit 150
provides an indication to the caregiver. The indication that the
pressure set-up pattern has been followed may be different than the
indication that the pressure set-up pattern has not been
followed.
[0038] Referring now primarily to FIGS. 3-5C, an illustrative
embodiment of the reduced-pressure interface 116 is presented in
more detail. The reduced-pressure interface 116 includes a housing
158, a conduit port 168 coupled to the housing 158, and the
attachment device 152 for coupling the reduced-pressure interface
116 to the sealing member 114. The reduced-pressure interface 116
further includes the cutting element 118.
[0039] The housing 158 may have a flange portion 160 and a cavity
wall portion 162. The cavity wall portion 162 forms a cavity 164
having a tissue-facing cavity opening 166. The conduit port 168 is
coupled to or formed as part of the cavity wall portion 162 of the
housing 158. The conduit port 168 includes a conduit aperture 170
whereby the conduit port 168 is adapted to receive the
reduced-pressure delivery conduit 110. The attachment device 138
may be coupled to a tissue-facing side 172 of the flange portion
160 for coupling the housing 158 to the first side 134 of the
sealing member 114. The housing 158 is made of a semi-rigid
material that is capable of collapsing under a force such as a
driving force 174. In a non-limiting example, the reduced-pressure
interface 116, and thus the housing 158, may be made from a
plasticized polyvinyl chloride (PVC), polyurethane, cyclic olefin
copolymer elastomer, thermoplastic elastomer, poly acrylic,
silicone polymer, and polyether block amide copolymer.
[0040] The cutting element 118 may be at least temporarily coupled
to the housing 158 proximate to the tissue-facing cavity opening
166. The cutting element 118 is adapted to form the aperture 120 in
the sealing member 114 when the cutting element 118 is driven into
the sealing member 114 with the driving force 174. The driving
force 174 may also cause the cutting element 118 to penetrate or
cut a portion of the distribution manifold 112. The driving force
174 may be manually applied to an exterior 184 of the
reduced-pressure interface 116 causing the housing 158 to collapse
and thereby driving or pushing the cutting element 118 into the
sealing member 114. In another embodiment, the driving force 174 is
applied by applying reduced pressure to the cavity 164 such that a
cavity pressure (P.sub.c) in the cavity 164 is less than a
threshold pressure (P.sub.t). When the cavity pressure (P.sub.c) is
less than the threshold pressure (P.sub.t), the cavity wall portion
162 collapses and with continued reduced pressure impacts the
cutting element 118 thereby driving a portion of the cutting
element 118 through the sealing member 114. The threshold pressure
(P.sub.t) is at least in part dependent on the type and thickness
of the material used for the housing 158. In the event reduced
pressure is applied to the cavity 164, a tensile force may be
applied to the sealing member 114 causing the sealing member 114 to
pull into the cavity 164. This movement further assists with the
cutting element 118 moving into the sealing member 114.
[0041] In one embodiment, the cutting element 118 includes a base
member 176 and a stylus member 178 coupled to the base member 176.
The stylus member 178 has a leading edge 180 and is configured to
perforate the sealing member 114 to form the aperture 120 in the
sealing member 114. In one embodiment, the leading edge 180 is
serrated. In another embodiment, the leading edge 180 is serrated
or configured to perforate the sealing member 114 orthogonally. The
sealing member 114 may be perforated orthogonally to inhibit the
cut sealing member 114 from blocking the reduced-pressure delivery
conduit 110 during reduced pressure therapy. The base member 176
may be sized and configured to form an interference fit with the
tissue-facing cavity opening 166, whereby the cutting element 118
is releasably coupled to the housing 158. Thus, in one embodiment,
the cutting element 118 may be removed prior to use if not desired
or after perforating the sealing member 114.
[0042] The cutting element 118 may have a piercing length (L.sub.p)
extending the length (L) of the stylus member 178. The length (L)
of the stylus member 178 extends from the base member 176 to a tip
182 of the stylus member 178. In one embodiment, the piercing
length (L.sub.p) is less than 3 centimeters. In another embodiment,
the piercing length (L.sub.p) is less than 2 centimeters. The
distribution manifold 112 may have a thickness greater than T when
subject to reduced pressure such that the piercing length (L.sub.p)
of the cutting element 118 is less than the thickness T, i.e.,
L.sub.p<T. One benefit of the piercing length (L.sub.p) being
less than the thickness, T, of the distribution manifold 112 under
reduced pressure is that the cutting element 118 cannot completely
cut through the distribution manifold 112 and reach the tissue site
102.
[0043] As previously mentioned, the cutting element 118 may be only
temporarily coupled to the housing 158. In one embodiment, the
cutting element 118 may be removed by a care giver. In another
embodiment, the cutting element 118 may be formed from a liquid
soluble material such as a water soluble material adapted to allow
the cutting element 118 to dissolve. For example, the water soluble
material may include at least one of the following: Polyvinyl
alcohol (PVOH), polyvinyl pyrrolidone, hydroxyl and carboxyl
modified cellulose, hydroxyl and carboxyl modified acrylics,
starch, sugars (sucrose, glucose, fructose), weak acids (tartaric,
citric, malic), salts (sodium chloride, sodium carbonate, sodium
bicarbonate), polyethylene oxide (PEO), polyethylene glycol (PEG).
The cutting element 118 may dissolve as liquids are removed from
the tissue site 102. Reduced pressure is applied to the
reduced-pressure interface 116 after perforating the sealing member
114 typically causing liquids to be removed from the tissue site
102. After a sufficient amount of time, liquids removed from the
tissue site 102 cause the cutting element 118 to substantially
dissolve. The cutting element 118 may dissolve within 2 minutes, 5
minutes, 10 minutes, or another time period. As the cutting element
118 is dissolved it is removed by the reduced-pressure delivery
conduit 110 with liquids from the tissue site 102. A liquid, e.g.,
saline solution, may also be introduced through the
reduced-pressure delivery conduit 110 or otherwise to dissolve the
cutting element 118.
[0044] As shown in FIG. 5C, once the cutting element 118 has
substantially dissolved, reduced pressure applied through the
reduced-pressure interface 116 creates sufficient reduced pressure
in the cavity 164 to pull a portion of the distribution manifold
112 into the cavity 164 such that the distribution manifold 112
abuts a distal end of the reduced-pressure delivery conduit 110 to
include a distal aperture 186 of the at least one sensing lumen
144. Allowing the distribution manifold 112 to completely abut the
distal end of the reduced-pressure delivery conduit 110 may help
ensure fluid isolation between each of the lumens in the
reduced-pressure delivery conduit 110. The distribution manifold
112 may provide a barrier between the primary lumen 142 and the at
least one sensing lumen 144. Additionally, having the
reduced-pressure delivery conduit 110 in direct contact with the
distribution manifold 112 may help ensure that there is a constant
low velocity liquid flow into the reduced-pressure delivery conduit
110 which may minimize the instance of aerosolized particles being
deposited around the at least one sensing lumen 144 and may also
provide a filter to liquids entering the at least one sensing lumen
144.
[0045] In operation, a caregiver may treat the tissue site 102 on
the patient 104 with a method that includes disposing the
distribution manifold 112 proximate to the tissue site 102. The
distribution manifold 112 and a portion of intact epidermis 124 of
the patient 104 is covered with the sealing member 114 to form the
sealed space 132 in which the distribution manifold 112 is
disposed. The reduced-pressure interface 116 is coupled to the
sealing member 114. The reduced-pressure delivery conduit 110 is
fluidly coupled on one end to the reduced-pressure source 140 and
on the opposing end to the reduced-pressure interface 116. The
driving force 174 is then applied to the reduced-pressure interface
116 with sufficient strength to cause the cutting element 118 to
perforate (e.g., pierce, tear, cut or otherwise create the aperture
120) the sealing member 114.
[0046] In one embodiment, the reduced-pressure interface 116
includes the housing 158 having the wall portion, wherein the wall
portion forms the cavity 164 having the tissue-facing cavity
opening 166. The housing 158 is formed of a semi-rigid material
that collapses when under reduced pressure less than the threshold
pressure (P.sub.t). The conduit port 168 is coupled to the wall
portion of the housing 158. The conduit port 168 is further coupled
to the reduced-pressure delivery conduit 110. Reduced pressure is
supplied to the reduced-pressure interface 116 through the
reduced-pressure delivery conduit 110 and the conduit port 168.
When reduced pressure levels in the cavity 164 are less than the
threshold pressure (P.sub.t), the wall portion collapses under the
driving force 174 and impacts the cutting element 118, driving a
portion of the cutting element 118 through the sealing member 114
to perforate the sealing member 114.
[0047] In one embodiment, in response to the sealing member 114
being perforated, liquid is removed from the tissue site 102
through the reduced-pressure delivery conduit 110. Liquid is
removed from the tissue site 102 by virtue of reduced pressure. The
liquid causes the cutting element 118 to dissolve. Once the cutting
element 118 has substantially dissolved, reduced pressure within
the cavity 164 of the reduced-pressure interface 116 causes a
portion of the distribution manifold 112 to be pulled into the
cavity 164 and abut the reduced-pressure delivery conduit 110.
Fluid may then be directly transferred from the distribution
manifold 112 to the reduced-pressure delivery conduit 110 without
going through an additional medium or open space.
[0048] Referring now primarily to FIGS. 6-9C, another illustrative
embodiment of a reduced-pressure interface 216 is presented. The
reduced-pressure interface 216 is analogous in many respects to the
reduced-pressure interface 116 of FIGS. 3-5C. The reduced-pressure
interface 216 includes a housing 258 and a cutting element 218. The
housing 258 may have a flange portion 260 and a cavity wall portion
262. The flange portion 260 may be coupled to the sealing member
114 by the attachment device 138. The cavity wall portion 262 is
collapsible under reduced pressure. The cavity wall portion 262 may
include a bellows configuration 290 for permitting the cavity wall
portion 262 to collapse when a cavity 164 pressure (P.sub.c) inside
a cavity 264 is less than a threshold pressure (P.sub.t) on an
absolute pressure side.
[0049] The cutting element 218 may include a conduit adapter 292,
an adapter flange 294, a tube extension 296, a base member 276, and
a stylus member 278. The conduit adapter 292 is configured to
receive the reduced-pressure delivery conduit 110 to provide fluid
communication between the reduced-pressure treatment unit 108 and
the tissue site 102. The conduit adapter 292 includes a protrusion
293 for engaging the primary lumen 142 of the reduced-pressure
delivery conduit 110. The protrusion 293 may be sized and
configured to extend into the primary lumen 142 and to form an
interference fit. The protrusion 293 may help maintain fluid
isolation between the primary lumen 142 and the at least one
sensing lumen 144. The adapter flange 294 is positioned on an
exterior 284 of the cavity wall portion 262. The tube extension 296
is connected to the adapter flange 294 and is sized and configured
to mate with a conduit aperture 298. The tube extension 296 is
further configured to extend through the conduit aperture 298. In a
specific, non-limiting example, the conduit adapter 292, the
adapter flange 294, and the tube extension 296 may be formed from
materials to include plasticized polyvinyl chloride (PVC),
polyurethane, cyclic olefin copolymer elastomer, thermoplastic
elastomer, poly acrylic, silicone polymer, and polyether block
amide copolymer.
[0050] The base member 276 may be at least temporarily coupled to
the tube extension 296. The stylus member 278 is directly coupled
to the base member 276 and may include a first blade 297 and a
second blade 299 configured to make orthogonal cuts in the sealing
member 114 when the housing 258 is compressed with a driving force
thereby impacting the cutting element 218. The stylus member 278 is
thus driven into the sealing member 114. The driving force may be
manually applied to the exterior 284 of the reduced-pressure
interface 216 causing the housing 258 to collapse and thereby
driving or pushing the cutting element 218 into the sealing member
114. In another embodiment, the driving force is applied by
applying reduced pressure to the cavity 264 such that the cavity
pressure (P.sub.c) in the cavity 264 is less than a threshold
pressure (P.sub.t). When the cavity pressure (P.sub.c) in the
cavity 264 is less than the threshold pressure (P.sub.t), the
cavity wall portion 262 collapses and impacts the cutting element
218. With continued reduced pressure, a portion of the cutting
element 218 is driven through the sealing member 114. The threshold
pressure (P.sub.t) is at least in part dependent on the type and
thickness of material used for the housing 258. In the event
reduced pressure is applied to the cavity 264, a tensile force 273
may be applied to the sealing member 114 causing the sealing member
114 to be pulled into the cavity 264. This movement helps the
cutting element 218 to be driven into the sealing member 114.
[0051] As previously mentioned, the base member 276 may be only
temporarily coupled to the housing 258. In one embodiment, the base
member 276 and the stylus member 278 may be formed from a liquid
soluble material such as a water soluble material adapted to allow
the cutting element 118 to dissolve. The water soluble material may
include at least one of the following: Polyvinyl alcohol (PVOH),
polyvinyl pyrrolidone, hydroxyl and carboxyl modified cellulose,
hydroxyl and carboxyl modified acrylics, starch, sugars (sucrose,
glucose, fructose), weak acids (tartaric, citric, malic), salts
(sodium chloride, sodium carbonate, sodium bicarbonate),
polyethylene oxide (PEO), polyethylene glycol (PEG). The base
member 276 and the stylus member 278 may dissolve as liquids are
removed from the tissue site 102. Reduced pressure is applied to
the reduced-pressure interface 216 typically causing liquids to be
removed from the tissue site 102. After a sufficient amount of
time, liquids removed from the tissue site 102 may cause the base
member 276 and the stylus member 278 to substantially dissolve. The
base member 276 and the stylus member 278 may dissolve within 2
minutes, 5 minutes, 8 minutes, 10 minutes, or another time period.
As the base member 276 and the stylus member 278 are dissolved, the
base member 276 and the stylus member 278 are removed by the
reduced-pressure delivery conduit 110 with the liquids from the
tissue site 102. While the base member 276 and the stylus member
278 may be dissolvable, it is worth noting that the conduit adapter
292, the adapter flange 294, and the tube extension 296 do not
dissolve.
[0052] Once the base member 276 and the stylus member 278 have
substantially dissolved, reduced pressure applied through the
reduced-pressure interface 216 creates sufficient reduced pressure
in the cavity 264 to pull a portion of the distribution manifold
112 into the cavity 264 and the primary lumen 142 of the
reduced-pressure delivery conduit 110. The distribution manifold
112 abuts the distal end of the reduced-pressure delivery conduit
110 including the distal aperture 186 of the at least one sensing
lumen 144. Allowing the distribution manifold 112 to completely
abut the distal end of the reduced-pressure delivery conduit 110
may help ensure fluid isolation between each of the lumens in the
reduced-pressure delivery conduit 110.
[0053] Referring now primarily to FIG. 10, a schematic diagram of a
pressure set-up pattern is presented. The pressure set-up pattern
may be a pre-determined pressure configuration. Pressure-detection
sensors may communicate with a processing unit to monitor whether
pressure signals received from a reduced-pressure interface follow
or is consistent with the pressure set-up pattern. The pressure
set-up pattern may be representative of whether a cutting element
of the reduced-pressure interface has pierced a sealing member. The
pressure set-up pattern may represent four main events. First, a
period of sustained pressure decrease (reduced pressure increase)
may be indicative of a period of time prior to the cutting element
piercing the sealing member. This segment is shown generally by
reference numeral 302. During this period of time, pressure is
decreasing in a cavity of the reduced-pressure interface causing
the cavity to collapse. Second, a threshold pressure (P.sub.t) is
reached and pressure increases (reduced pressure decreases)
indicating that the cutting element has pierced the sealing member.
This segment is generally shown by numeral 304. The pressure should
increase as the pressure in the sealed space beneath the sealing
member stabilizes. And third, a period of pressure stability is
reached as shown generally as reference numeral 306.
[0054] Although the present invention and its advantages have been
disclosed in the context of certain illustrative, non-limiting
embodiments, it should be understood that various changes,
substitutions, permutations, and alterations can be made without
departing from the scope of the invention as defined by the
appended claims. It will be appreciated that any feature that is
described in connection to any one embodiment may also be
applicable to any other embodiment.
[0055] It will be understood that the benefits and advantages
described above may relate to one embodiment or may relate to
several embodiments. It will further be understood that reference
to `an` item refers to one or more of those items.
[0056] The steps of the methods described herein may be carried out
in any suitable order, or simultaneously where appropriate.
[0057] Where appropriate, aspects of any of the examples described
above may be combined with aspects of any of the other examples
described to form further examples having comparable or different
properties and addressing the same or different problems.
[0058] It will be understood that the above description of
preferred embodiments is given by way of example only and that
various modifications may be made by those skilled in the art. The
above specification, examples and data provide a complete
description of the structure and use of exemplary embodiments of
the invention. Although various embodiments of the invention have
been described above with a certain degree of particularity, or
with reference to one or more individual embodiments, those skilled
in the art could make numerous alterations to the disclosed
embodiments without departing from the scope of the claims.
* * * * *